Home/Filings/4/0001567619-21-013660
4//SEC Filing

Omega Fund VI, L.P. 4

Accession 0001567619-21-013660

CIK 0001623715other

Filed

Jul 18, 8:00 PM ET

Accepted

Jul 19, 7:03 PM ET

Size

5.6 KB

Accession

0001567619-21-013660

Insider Transaction Report

Form 4
Period: 2021-07-15
Transactions
  • Purchase

    Common Stock

    2021-07-15$16.00/sh+250,000$4,000,000250,000 total
Footnotes (1)
  • [F1]The reported securities are beneficially owned by Omega Fund VI, L.P. ("Omega VI"). The reported securities may be deemed to be beneficially owned by each of Omega Fund VI GP, L.P. ("Omega VI GP"), as the general partner of Omega VI, and Omega Fund VI GP Manager, Ltd. ("Omega VI GP Manager"), as the general partner of Omega VI GP. Otello Stampacchia, Claudio Nessi and Anne-Mari Paster are all the shareholders and directors of Omega VI GP Manager and have shared voting and investment power over the shares held by Omega VI and, as a result, may each be deemed to beneficially own the reported securities. Each of such individuals disclaims beneficial ownership of the shares held by Omega VI.

Documents

1 file

Issuer

Imago BioSciences, Inc.

CIK 0001623715

Entity typeother
IncorporatedCayman Islands

Related Parties

1
  • filerCIK 0001757917

Filing Metadata

Form type
4
Filed
Jul 18, 8:00 PM ET
Accepted
Jul 19, 7:03 PM ET
Size
5.6 KB